MESO
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Mesoblast receives FDA approval for a new potency assay used to release commercial Ryoncil productSep 24, 2026
- Mesoblast achieved a major milestone by completing patient treatment in its pivotal Phase 3 trial for chronic low back painAug 17, 2026
- Mesoblast reached its target of treating 300 patients in its pivotal Phase 3 trial for chronic low back painJul 14, 2026
- Mesoblast received a BLA filing number and requested a modular review for Rexlemestrocel-LJul 1, 2026
- Mesoblast reached its patient recruitment target in the pivotal Phase 3 trial for chronic low back painApr 29, 2026